University of Alabama at Birmingham
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Alabama at Birmingham sits in the top decile of US sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count).
University of Alabama at Birmingham: 1,160 sponsored US clinical trials, 216 recruiting.
University of Alabama at Birmingham sponsors 1,160 registered US clinical trials on ClinicalTrials.gov, 216 of them currently recruiting, and 723 completed. 97 of these trials are in Phase 3-4 (later-stage) and 259 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
University of Alabama at Birmingham ranks in the top decile of sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
723 of 812 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,160 total, page 11 of 24
Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits
NCT04328207
Return of Aspiration-Free Swallow After Laryngotracheal Anesthesia
NCT04575870
Compression Nail for Tibiocalcaneal Arthrodesis
NCT03780452
Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS)
NCT04581811
Daily Self-Weighing for Obesity Management in Primary Care
NCT04044794
Examining the Neural Effects of a Behavioral Intervention for Physical Activity in Multiple Sclerosis
NCT04496804
Adherence and Outcomes in Functional Constipation With a Constipation Action Plan
NCT04614935
Baclofen as a Perioperative Analgesic Adjuvant
NCT03720717
Gait Training Combined With Behavioral Strategies for People With Stroke
NCT04546217
Daughters, dUdes, Mothers and othErs Fighting Cancer Together
NCT04132219
Maximizing Acute Kidney Injury End-point Intervention Post-Discharge (MAKE-IT) Study
NCT04358874
Investigating Racial Differences in Diet Benefits for Knee Osteoarthritis
NCT04343716
Time Restricted Eating Outcomes in Multiple Sclerosis
NCT04389970
Piloting Home-based Movement-to-Music Among Adolescents With Cerebral Palsy: A Randomized Controlled Trial
NCT04264390
Testing Scalable, IVR-supported Cancer Prevention Interventions in the Rural Alabama Black Belt
NCT03903874
Decreased Neuraxial Morphine After Cesarean Delivery
NCT04279054
GKT137831 in IPF Patients with Idiopathic Pulmonary Fibrosis
NCT03865927
Sleep and Stigma: Novel Moderators in the Relationship Between Weight Status and Cognitive Function
NCT04346433
Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection
NCT04164212
A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders
NCT03767517
Effect of High Carbohydrate vs. Low Carbohydrate Diet in Type 2 Diabetes
NCT04416204
PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study
NCT04086966
Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care
NCT03670316
The Role of Pre-deployment Retraction in Decreasing Biopsy Clip Migration During Stereotactic Breast Biopsies
NCT04398537
Early Treatment of Cytokine Storm Syndrome in Covid-19
NCT04362111
A Trial to Assess the Safety and Efficacy of KRN23 in Epidermal Nevus Syndrome (ENS)
NCT04320316
Implementation of a Cardiometabolic Disease Staging System in Primary Care
NCT04922294
TOSS Feasibility + Fitbit Community = Reduced Obesity in Older Black Women
NCT04114071
Timing of Sodium Intake and Nocturnal Sodium Excretion and Blood Pressure in Obese African Americans
NCT04021355
Preoperative Regional Nerve Block for Acute and Chronic Post-Operative Pain Following Mastectomy
NCT04019834
Healthcare Utilization in Obese Caregiver Living Donors
NCT04341896
Acceptance and Commitment Therapy for Family Caregivers of People With Dementia
NCT04458870
To Compare Ridge Preservation Technique Using Leukocyte Platelet Rich Fibrin (L-PRF) and Freeze-dried Bone Allograft (FDBA) Layered Technique vs L-PRF/FDBA and L-PRF Alone in Influencing Quantity and Quality of New Bone Formation in Grafted Extraction Sockets
NCT04133363
To Measure Pain Perception Following De-Epithelized Free Gingival Graft Harvesting
NCT03895476
Dissemination and Implementation of Stroke Prevention Looking at the Care Environment
NCT04173026
TXA and Corona Virus 2019 (COVID19) in Outpatients
NCT04338074
Comparing Modes of Telehealth Delivery: Phone vs. Video Visits (ASSIST)
NCT04616118
VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease
NCT04587323
A Health and Wellness Lifestyle Program to Support Community-Dwelling Persons With Traumatic Brain Injury
NCT04288258
Ketone Supplementation in Adolescents Post-Concussion
NCT04079907
The Innate Central Nervous System Immune Response to an Experimental Immune Challenge in People With Fibromyalgia
NCT04263454
Technology-enabled Patient Support System for Self-management of CF
NCT03910881
Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
NCT04283669
Open-Label Placebos to Treat Fatigue in Multiple Sclerosis
NCT04002102
Sling Use and Functional Mobility in a Geriatric Population
NCT03921619
Acute Headache Treatment in Pregnancy: Occipital Nerve Block vs PO Acetaminophen With Caffeine
NCT03951649
RAD 1801: Pilot Study of Intra-Urethral Radiotransponder Beacon Guided Focal Prostate Stereotactic Body Radiotherapy
NCT03458234
Using Interactive Virtual Presence to Remotely Assist Parents With Child Restraint Installations
NCT03877744
YES! We Can PLAY: A Physical Activity and Nutrition After-School Program for Middle School Students
NCT04132869
Regional Block for Postoperative Free Flap Care
NCT04080739
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 129 |
| Phase 2 | 130 |
| Phase 3 | 25 |
| Phase 4 | 72 |
Therapeutic Areas
What is open in the University of Alabama at Birmingham pipeline
216 recruiting of 1,160 indexed (19% open); 723 completed (62%).
Phase mix: 97 late (III/IV) vs 259 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Alabama at Birmingham: open-pipeline peers nationwide
Peers matched on 1,160 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Alabama at Birmingham sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,160 trials (± recruiting share)
- NYU Langone Health · 1,164 trials · 17% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Minnesota · 19% recruiting · 966 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Alabama at Birmingham page
1,160 registered trials is a research-attention snapshot, not an endorsement of University of Alabama at Birmingham or any single study.
- 216 of University of Alabama at Birmingham's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Alabama at Birmingham studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Alabama at Birmingham pipeline card: 1,160 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.